In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 230.7 | 226.0 | 221.4 | 148.2 | 110.3 | 93.4 | 85.4 | 50.2 |
Interest income on investments | 21.8 | 15.5 | 9.9 | 8.5 | 8.4 | 6.9 | 3.1 | 1.9 |
| 253.2 | 241.8 | 232.9 | 158.2 | 119.4 | 100.8 | 88.8 | 52.4 |
Interest expense: |
| 24.6 | 39.1 | 53.4 | 29.6 | 15.8 | 10.9 | 8.6 | 5.6 |
Net interest income | 228.6 | 202.7 | 179.5 | 128.6 | 103.7 | 89.9 | 80.2 | 46.8 |
Provision for loan losses | -2.3 | 27.4 | 5.9 | 4.2 | 13.2 | 5.5 | 5.8 | 2.2 |
Net interest income after provision for loan losses | 230.9 | 175.3 | 173.6 | 124.3 | 90.5 | 84.4 | 74.4 | 44.7 |
Deposit and loan fees | | | | | | | 0.7 | 0.5 |
Gain on sale of investments, net | | | | | | | 0.0 | 0.1 |
Other non-interest income | 8.6 | 8.2 | 13.4 | 7.7 | 5.9 | 7.3 | 3.3 | 2.0 |
Total non-interest income | 8.6 | 8.2 | 13.4 | 7.7 | 5.9 | 7.3 | 4.0 | 2.6 |
Non-interest expenses | 139.6 | 127.5 | 120.6 | 86.8 | 70.0 | 59.3 | 54.8 | 33.5 |
Pre-tax income before non-recurring items | 101.9 | 56.0 | 67.7 | 46.9 | 26.4 | 32.4 | 23.6 | 13.8 |
Non-recurring items | 2.0 | | 1.3 | 1.7 | | | | |
Pre-tax income | 99.9 | 56.0 | 66.4 | 45.3 | 26.4 | 32.4 | 23.6 | 13.8 |
Income taxes | 18.3 | 10.4 | 13.4 | 7.9 | 8.7 | 9.6 | 7.8 | 4.8 |
Tax rate | 18.4% | 18.6% | 20.2% | 17.6% | 33.2% | 29.5% | 33.0% | 34.9% |
Net income | 81.6 | 45.5 | 53.0 | 37.3 | 17.6 | 22.9 | 15.2 | 9.0 |
Net margin | 34.1% | 24.8% | 28.3% | 28.3% | 18.3% | 24.9% | 19.4% | 19.0% |
|
Basic EPS | $4.04 | $2.23 | $2.50 | $2.41 | $1.34 | $1.78 | $1.45 | $1.29 |
Diluted EPS | $4.01 | $2.22 | $2.47 | $2.37 | $1.31 | $1.75 | $1.43 | $1.26 |
|
Shares outstanding (basic) | 20.2 | 20.4 | 21.2 | 15.5 | 13.1 | 12.9 | 10.5 | 7.0 |
Shares outstanding (diluted) | 20.4 | 20.5 | 21.4 | 15.8 | 13.5 | 13.1 | 10.7 | 7.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |